Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

 Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.

71. Regeneron’s REGN-COV2 Demonstrate Reduction in Viral Load and Improve Symptoms in Non-Hospitalized Patients with COVID-19

Sept 30, 2020 | Clinical Trial

70. Doctors in Lowell Report Positive Outcomes for Second COVID-19 Patient Treated with Laser Therapy

Sept 29, 2020 | Clinical Trial

69. Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites

Sept 29, 2020 | Clinical Trial

68. Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19

Sept 28, 2020 | Clinical Trial

67. COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan

Sept 28, 2020 | Clinical Trial

63. INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800

Sept 28, 2020 | Regulatory

62. FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica’s itMSC Therapy for COVID-19 Patients

Sept 28, 2020 | Regulatory

61. Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study

Sept 28, 2020 | Clinical Trial

60. Parade/Cleveland Clinic ‘Healthy Now’ Survey Reveals Positive Long-term Effects of COVID-19 Pandemic: Embracing Healthy Lifestyle Changes, Valuing Personal Relationships, Finding Meaning, Remaining Hopeful

Sept 25, 2020 | Clinical Trial

59. Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK

Sept 25, 2020 | Clinical Trial

58. JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study

Sept 24, 2020 |

57. Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay from Abacus Diagnostica

Sept 23, 2020 | Diagnostic

56. J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

Sept 24, 2020 | Clinical Trial

55. DURECT Corporation Announces First Patient Dosed in Phase 2 Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury

Sept 23, 2020 | Clinical Trial

54. Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

Sept 23, 2020 | Collaboration

53. Avigan Shows Promising Results in Treatment of COVID Patients in Japan

Sept 23, 2020 | Clinical Trial

52.  FDA Authorizes First Point-of-Care Antibody Test for COVID-19

Sept 23, 2020 | Diagnostic

51. DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program

Sept 22, 2020 | DigiHealth

50. FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress

Sept 21, 2020 | Regulatory

49. Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device

Sept 21, 2020 | Collaboration

48. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia

Sept 18, 2020 | Clinical Trial

47. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Sept 18, 2020 | Diagnostic

46. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

Sept 18, 2020 | Collaboration

45. NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases

Sept 18, 2020 | Clinical Trial

44. Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial

Sept 18, 2020 | Clinical Trial

43. HSS Funds Innovative Research on COVID-19

Sept 18, 2020 | Grant

42. Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

Sept 18, 2020 | Clinical Trial

41. Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova

Sept 17, 2020 | Clinical Trial

40. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients

Sept 17, 2020 | Clinical Trial

39. CEBINA Reports Positive Findings on the Potency of Azelastine

Sept 17, 2020 | Clinical Trial

38. Seattle AVM Biotechnology Announces Second IND for AVM0703: Clinical Trial Permitted to Treat COVID-19 and Influenza ARDS with its “supercharged” Version of Dexamethasone

Sept 16, 2020 | Regulatory

37. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting

Sept 16, 2020 | Clinical Trial

36. Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance

Sept 15, 2020 | Clinical Trial

35. FUJIFILM Sonosite and the CHEST Foundation Partner for COVID-19 Research

Sept 15, 2020 | Collaboration

34. BenevolentAI’s Platform-Derived Hypothesis for COVID-19 Treatment Validated in US NIAID Randomised Control Trial

Sept 14, 2020 | Clinical Trial

33. Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News

Sept 14, 2020 | Clinical Trial

32. Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada

Sept 14, 2020 | Diagnostics

31. Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122

Sept 14, 2020 | Diagnostics

30. RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK

Sept 14, 2020 | Clinical Trial

29. Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial

Sept 14, 2020 | Clinical Trial

28. Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine

Sept 14, 2020 | Collaboration

27. Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient – Discharged Following Five Days of Treatment

Sept 11, 2020 | Regulatory

26. Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU

Sept 10, 2020 | Collaboration

25. New Study Published in PLOS Medicine Explores Impact of Race, Age & Comorbidities on COVID-19 Mortality

Sept 10, 2020 | Clinical Trial

24. Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial

Sept 09, 2020 | Clinical Trial

23. Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study

Sept 09, 2020 | Clinical Trial

22. Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients

Sept 09, 2020 | Clinical Trial

21. The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19

Sept 09, 2020 | Clinical Trial

20. New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims

Sept 09, 2020 | Diagnostics

19. DPHARM Presents the Largest Number of Sessions Across R&D on Decentralized Clinical Trials Due to COVID-19

Sept 09, 2020 | Clinical Trial

18. Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19

Sept 08, 2020 | Clinical Trial

17. Celularity Doses First Patient in Clinical Trial Evaluating CYNK-001 in COVID-19 Patients

Sept 08, 2020 | Clinical Trial

16. Co-Diagnostics Enters into Agreement with Arches Research to Expand COVID-19 Testing Services

Sept 08, 2020 | Collaboration

14. CytoSorbents Reports the “CytoSorb Therapy in COVID-19 ICU Patients” (CTC) Registry Is Actively Enrolling

Sept 08, 2020 | Clinical Trial

13. Ampio Reports Enrollment Completion for IV COVID-19 Clinical Trial & Provides Update on OAK Clinical Trial

Sept 04, 2020 |Clinical Trial

12. DetectaChem Receives FDA EUA Authorization for Mobile COVID-19 Detection Technology

Sept 03, 2020 | DigiHealth

11. Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine

Sept 03, 2020 | Clinical Trial

10. Experts at CenExel Clinical Research Sites Tackle COVID-19 Vaccine Testing

Sept 02, 2020 | Clinical Trial

9. ANVISA Authorizes Dompé’s REPAVID-19 P-II Study for Treatment of Severe Patients

Sept 02, 2020 | Approval

8. Sanford Health Initiates P-Ib Study of SAB-185 Against COVID-19

Sept 02, 2020 | Clinical Trial

7. Pulmonem Receives Health Canada Approval to Initiate P-III Clinical Study for COVID-19

Sept 02, 2020 | Regulatory

6. AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19

Sept 01, 2020 | Collaboration

5. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19

Sept 01, 2020 | Collaboration

4. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

Sept 01, 2020 | Clinical Trial

3. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Sept 01, 2020 | Collaboration

2. Aerpio and Quantum Leap Report First Patients Dosing with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-Ill COVID-19 Patients

Sept 01, 2020 | Clinical Trial

1. Rowpar Pharmaceuticals Demonstrate ClōSYS Ultra Sensitive Oral Rinse Reduced SARS-CoV-2 Infection

Sept 01, 2020 | Clinical Trial

Related News: Insights+: COVID-19 Healthcare News Monthly Updates – August 2020

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post